Cost-utility analysis of genotype-guided antiplatelet therapy in patients with moderate-to-high risk acute coronary syndrome and planned percutaneous coronary intervention
about
Cost-utility analysis of genotype-guided antiplatelet therapy in patients with moderate-to-high risk acute coronary syndrome and planned percutaneous coronary intervention
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cost-utility analysis of genot ...... utaneous coronary intervention
@ast
Cost-utility analysis of genot ...... utaneous coronary intervention
@en
Cost-utility analysis of genot ...... utaneous coronary intervention
@nl
type
label
Cost-utility analysis of genot ...... utaneous coronary intervention
@ast
Cost-utility analysis of genot ...... utaneous coronary intervention
@en
Cost-utility analysis of genot ...... utaneous coronary intervention
@nl
prefLabel
Cost-utility analysis of genot ...... utaneous coronary intervention
@ast
Cost-utility analysis of genot ...... utaneous coronary intervention
@en
Cost-utility analysis of genot ...... utaneous coronary intervention
@nl
P2093
P2860
P1433
P1476
Cost-utility analysis of genot ...... utaneous coronary intervention
@en
P2093
Daniel R Touchette
Olaitan Ojo
Shengsheng Yu
Vardhaman Patel
P2860
P356
10.4321/S1886-36552014000300007
P50
P577
2014-07-01T00:00:00Z